JUN 17, 2019 7:59 AM PDT

Promising Hypertension Drug for Alzheimer Disease

WRITTEN BY: Nouran Amin

In a study led by the American Heart Association, the blood pressure drug nilvadipine (a calcium channel blocker) was found to increase blood flow to the brains memory and learning center in individuals with Alzheimer's disease without adverse effects to other regions of the brain. The study was published in the journal Hypertension and indicates that a decrease in cerebral blood flow in patients with Alzheimer's can be reversed in some regions.

Alzheimer disease is a form of dementia with a risk that increases with age. Causes for Alzheimer disease still remain unknown but earlier studies have shown that blood flow to the brain declines in the early stages of Alzheimer disease. Other studies implied that possible high blood pressure treatment may reduce the risk of dementia possibly because of the beneficial effects on brain blood flow.

"This high blood pressure treatment holds promise as it doesn't appear to decrease blood flow to the brain, which could cause more harm than benefit," said study lead author Jurgen Claassen, M.D., Ph.D., associate professor at Radboud University Medical Center in Nijmegen, the Netherlands. "Even though no medical treatment is without risk, getting treatment for high blood pressure could be important to maintain brain health in patients with Alzheimer's disease."

Learn more about Alzheimer Disease:

 

 

"In the future, we need to find out whether the improvement in blood flow, especially in the hippocampus, can be used as a supportive treatment to slow down progression of Alzheimer's disease, especially in earlier stages of disease," Claassen said.

The study was the first to utilize MRI technique to observe the effects of treatment on cerebral blood flow.

Source: American Heart Association

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
JUN 13, 2020
Neuroscience
High Doses of Ketamine Can Switch Off the Brain
JUN 13, 2020
High Doses of Ketamine Can Switch Off the Brain
Researchers from the University of Cambridge, England, have found that high doses of ketamine temporarily switch off the ...
JUL 17, 2020
Drug Discovery & Development
Could Low-Dose Radiation Therapy Treat COVID-19?
JUL 17, 2020
Could Low-Dose Radiation Therapy Treat COVID-19?
Research from a century ago points towards the potential of low-dose radiation therapy (LDRT) for treating pneumonia. Ev ...
JUL 19, 2020
Neuroscience
Eating Fish May Protect Brain from Air Pollution
JUL 19, 2020
Eating Fish May Protect Brain from Air Pollution
Researchers have found that a diet high in omega-3 fatty acids may prevent neurodegeneration among older women living in ...
JUL 24, 2020
Cancer
A New Biomarker Candidate for Cancer Diagnostics
JUL 24, 2020
A New Biomarker Candidate for Cancer Diagnostics
One of the best tools in the fight against cancer is diagnostics. In 2018, colorectal cancer was the second most lethal ...
AUG 04, 2020
Drug Discovery & Development
Erectile Dysfunction Drug Cures Critical COVID-19 Patients
AUG 04, 2020
Erectile Dysfunction Drug Cures Critical COVID-19 Patients
Critically ill patients who received COVID-19 drug candidate aviptadil (RLF-100) were able to make a rapid recovery from ...
AUG 06, 2020
Immunology
Resetting the Body's Danger Sensor
AUG 06, 2020
Resetting the Body's Danger Sensor
The human body has a sophisticated danger-sensing mechanism that alerts the immune system when something is not right. T ...
Loading Comments...